Castle Biosciences, Inc. (CSTL)
24.81
+0.32
(+1.31%)
USD |
NASDAQ |
May 01, 16:00
24.83
+0.02
(+0.08%)
After-Hours: 20:00
Castle Biosciences EPS Diluted (Quarterly) : -0.0795 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Delcath Systems, Inc. | -0.052 |
| Assertio Holdings, Inc. | -1.858 |
| CytoSorbents Corp. | -0.0875 |
| Odyssey Health, Inc. | -0.0334 |
| Harmony Biosciences Holdings, Inc. | 0.3831 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.332M |
| Revenue (Quarterly) | 87.01M |
| Total Expenses (Quarterly) | 89.34M |
| Enterprise Value | 489.15M |
| Gross Profit Margin (Quarterly) | 75.87% |
| Profit Margin (Quarterly) | -2.68% |
| Earnings Yield | -3.41% |
| Normalized Earnings Yield | -3.508 |